In the office.

Chen Changan tapped the table lightly, pondered for a while, and said with some dissatisfaction: "So the State-owned Assets Group is unwilling to participate in financing because the risk of our company's product development is too high?"

Guan Kou nodded and said affirmatively: "Yes, just looking at our financial statements is still very eye-catching, but considering the subsequent R&D investment, they were discouraged."

"Don't they know that our R&D investment is not very high?" Chen Changan asked with a frown.

"Mr. Chen, this is not good and has standards. R&D investment is not constant. Even if we don't invest much in the previous project, we cannot guarantee that the next project will not become a bottomless pit for money. The person in charge of the State-owned Assets Department believes that with the development of the enterprise, there will definitely be more and more R&D investment."

"So, in their eyes, the only reason why Ruikang makes them unwilling to invest is the risk of R&D?"

Guan Kou supported the mirror frame and said cautiously: "It can be said that."

Chen Changan nodded slightly, and after he understood the details, he had a bold idea.

Since the State-owned Assets Group believes that Ruikang Medical's R&D risks are very high and does not want to take this risk, it is better to simply divest the R&D center from Ruikang Medical, set up an institution alone, and then sign an exclusive cooperation agreement with Ruikang.

In this way, the scientific research risks will no longer be distributed to Ruikang Medical. Ruikang only needs to undertake sales, promotion and operation work, and no longer bear the risk of R&D.

Chen Changan was short of money, but he was not short of R&D funds. Because he had black technology support, the cost in R&D funds was not particularly large, and there were rarely trial and error costs. As long as there were corresponding technical data, the limitation was only the problem of speed and slow research, and there would be no possibility of failure and wasting waste.

So he can actually afford the investment in product research and development. He can still make a contribution of 100 million or 200 million R&D funds per year.

What he lacks is to improve Ruikang's sales and after-sales channels, as well as to vigorously promote new products and promote promotions. He really can't afford this money for more than ten or two billion yuan.

The money raised this time is also used to invest in this area, and there is no intention to invest in R&D.

Since the R&D center does not need this financing, he might as well just divest R&D from Ruikang Medical.

Moreover, the independent R&D center only needs to sign an exclusive cooperation agreement with Ruikang, promising that the R&D center's products can be exclusively authorized to Ruikang Medical for operations. Then Ruikang's market value will not fluctuate too much, because Ruikang's interest line still has not changed.

However, if you do this, Ruikang will have to pay an additional cooperation fee. In the future, Ruikang will need to exchange money for every product developed by the R&D center.

But there is nothing wrong with this, at least for Chen Changan. Anyway, even if the R&D center is independent from Ruikang, it is still his company, and the money is just to turn the left hand into the right hand.

The one who loses is Ruikang's future financing shareholders.

But this is also the result they are willing to do. Since they don’t want to bear the risk of R&D losses, they don’t want to eat the dividends of R&D products for nothing.

Chen Changan himself bears the R&D risks of the R&D center, so the results made by the R&D center naturally belong to him alone.

This is fair!

It also suits the low risk that the State-owned Assets Group wants. As long as Ruikang Medical does not participate in R&D and is only responsible for sales, the risk will be greatly reduced. Judging from the current development situation, the sales of several products under Ruikang Medical are very stable and unlikely to lose money.

This will minimize the risk!

After thinking about it for a while, Chen Changan felt that this plan should be accepted.

"Guan Kou, you can draw up a few agreements to separate Ruikang's R&D department from the company, including the R&D center we are building, and to independently establish a subsidiary."

"The shares of this subsidiary are divided according to the current share ratio, and you also have 2% of the newly established R&D center."

"Since Chen Yun and Zhao Liuqing also followed suit and made great efforts in the construction of the R&D center, their 4.8% stake is also included."

"In this case, the shareholding of the new R&D company is me 93.2%, and you three together account for 6.8%."

Speaking of this, Chen Changan hesitated for a moment and said again: "Let's do this, take out 8% of my shares and build an option pool, which will give Bai Bingchun, Wang Jia, Yun Heng and the three of them a share of 1% of the shares. However, the options will be exercised in eight years. If you leave during the period, the remaining options will automatically return to the option pool, and if they want to sell, I have the right to repurchase."

If the exercise time is set to eight years, at least in the next eight years, these three people will not leave the R&D center in order to obtain this share option incentive, which is much more reliable than maintaining a simple employment contract.

Of course, the price paid is not small. If all 1% of options are exercised, they can at least become a billionaire.

"The remaining 5% will not be divided for the time being. As the part of establishing the option pool, I will go to the headhunter company to help me hire a professional financial talent. Since the R&D center wants to establish a company independently, it needs administrative talents to be responsible for the operation of the R&D company. Bai Bingchun is fine as the person in charge of the R&D office. He can't play with the company's operation level."

In the past, the R&D center belonged to Ruikang Medical, and the commercial operation was carried out by Ruikang’s administrative staff. Bai Bingchun only needed to manage R&D, and even the scientific research funds were approved by the company’s financial team.

Now that we have to be independent, we naturally need to set up a set of R&D center’s own administrative department and financial talents. Because Chen Changan wants to develop an option pool plan, the specific improvements still require talents who are proficient in finance to do it.

Now most large companies have their own complete stock option incentive model. If Ruikang wants to grow, he naturally needs to establish his own stock incentive plan so that excellent employees can be left behind and some senior management and outstanding scientific research talents will be tied to the carriage of Ruikang Medical and R&D Center.

This can lock the hearts of employees, increase their enthusiasm, increase their sense of identity, and also motivate employees to work hard to contribute to the company's development. Only when the company develops well can the options in their hands become more and more valuable.

If the 5% share option pool that Chen Changan took out is split and 10,000 yuan per share, it will be very, very much, enough to support the company's share incentive plan for a long time. This requires professional talents to plan carefully.

Let the option pool flow, both out and back, operate it healthily, and play its due role!
Chapter completed!